Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
42. The Protective Effect of Buprenorphine
42. The Protective Effect of Buprenorphine
42. The Protective Effect of Buprenorphine
Monday 3rd June 2024
Explore how buprenorphine protects against fentanyl overdose and the potential of semaglutide for alcohol use disorder in this engaging episode.
24 minutes
Informative
Engaging
Supportive
Educational
Hopeful
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
62 (View all)
Do you want to link to this podcast?
Get the buttons here!Buprenorphine's Life-Saving Role in Fentanyl Overdose
Episode Overview
- Buprenorphine can significantly reduce the risk of fatality during acute fentanyl exposures.
- Semaglutide shows promise in reducing alcohol cravings while aiding weight loss.
- Clinical experiences highlight the real-world impact of these treatments.
- Injectable treatments are gaining traction for their sustained protective effects.
- Staying updated with the latest research is crucial for effective addiction treatment.
I cheated death to record this podcast. I can't think of a better motivator
Get ready for a deep dive into the protective effects of buprenorphine on fentanyl overdose in this episode of the Addiction Medicine Journal Club. Hosts Dr. John Keenan and Dr. Sonia Del Tredici bring their expertise to the table, discussing groundbreaking research that could change how we view addiction treatment. They explore a study from the Journal of Substance Use and Addiction Treatment, which suggests that buprenorphine can significantly reduce the risk of fatality during acute fentanyl exposures.
The conversation is lively, with Sonia sharing her recent encounter with a bee sting, adding a touch of humour to an otherwise serious topic. The hosts don't stop at buprenorphine; they also delve into the potential of semaglutide for treating alcohol use disorder. Imagine a medication that not only helps with weight loss but also reduces alcohol cravings!
Sonia and John discuss case series data and their own clinical experiences, making this episode a treasure trove of practical insights for anyone involved in addiction medicine. You'll also hear about the real-world implications of these studies. John and Sonia talk about how these findings have influenced their clinical practices, from pushing for more injectable treatments to recruiting more prescribers. They stress the importance of staying updated with the latest research and invite listeners to share their thoughts and experiences.
If you're looking for an engaging, informative, and slightly humorous take on cutting-edge addiction research, this episode is a must-listen. Tune in to learn how buprenorphine and semaglutide could be game-changers in addiction treatment. Why not give it a listen and see how these insights could benefit your practice or personal journey?